Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 258

1.

Early inhaled nitric oxide therapy in premature newborns with respiratory failure.

Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C, Sekar KC, Auten RL, Bhutani VK, Gerdes JS, George TN, Southgate WM, Carriedo H, Couser RJ, Mammel MC, Hall DC, Pappagallo M, Sardesai S, Strain JD, Baier M, Abman SH.

N Engl J Med. 2006 Jul 27;355(4):354-64.

2.

Inhaled nitric oxide for premature infants with severe respiratory failure.

Van Meurs KP, Wright LL, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Higgins RD, Oh W, Hudak ML, Laptook AR, Shankaran S, Finer NN, Carlo WA, Kennedy KA, Fridriksson JH, Steinhorn RH, Sokol GM, Konduri GG, Aschner JL, Stoll BJ, D'Angio CT, Stevenson DK; Preemie Inhaled Nitric Oxide Study.

N Engl J Med. 2005 Jul 7;353(1):13-22.

3.

Inhaled nitric oxide in preterm infants undergoing mechanical ventilation.

Ballard RA, Truog WE, Cnaan A, Martin RJ, Ballard PL, Merrill JD, Walsh MC, Durand DJ, Mayock DE, Eichenwald EC, Null DR, Hudak ML, Puri AR, Golombek SG, Courtney SE, Stewart DL, Welty SE, Phibbs RH, Hibbs AM, Luan X, Wadlinger SR, Asselin JM, Coburn CE; NO CLD Study Group.

N Engl J Med. 2006 Jul 27;355(4):343-53. Erratum in: N Engl J Med. 2007 Oct 4;357(14):1444-5.

4.

Inhaled nitric oxide in premature infants with the respiratory distress syndrome.

Schreiber MD, Gin-Mestan K, Marks JD, Huo D, Lee G, Srisuparp P.

N Engl J Med. 2003 Nov 27;349(22):2099-107.

5.

Multicenter controlled clinical trial of high-frequency jet ventilation in preterm infants with uncomplicated respiratory distress syndrome.

Keszler M, Modanlou HD, Brudno DS, Clark FI, Cohen RS, Ryan RM, Kaneta MK, Davis JM.

Pediatrics. 1997 Oct;100(4):593-9.

PMID:
9310511
6.

Plasma biomarkers of oxidative stress: relationship to lung disease and inhaled nitric oxide therapy in premature infants.

Ballard PL, Truog WE, Merrill JD, Gow A, Posencheg M, Golombek SG, Parton LA, Luan X, Cnaan A, Ballard RA.

Pediatrics. 2008 Mar;121(3):555-61. doi: 10.1542/peds.2007-2479.

PMID:
18310205
7.

Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia.

Cole CH, Colton T, Shah BL, Abbasi S, MacKinnon BL, Demissie S, Frantz ID 3rd.

N Engl J Med. 1999 Apr 1;340(13):1005-10.

8.

Inhaled nitric oxide for preterm infants: a systematic review.

Barrington KJ, Finer NN.

Pediatrics. 2007 Nov;120(5):1088-99. Review. Erratum in: Pediatrics. 2008 Feb;121(2):451.

PMID:
17974747
9.

Inhaled nitric oxide for prevention of bronchopulmonary dysplasia in premature babies (EUNO): a randomised controlled trial.

Mercier JC, Hummler H, Durrmeyer X, Sanchez-Luna M, Carnielli V, Field D, Greenough A, Van Overmeire B, Jonsson B, Hallman M, Baldassarre J; EUNO Study Group.

Lancet. 2010 Jul 31;376(9738):346-54. doi: 10.1016/S0140-6736(10)60664-2. Epub 2010 Jul 23.

PMID:
20655106
10.

High-frequency oscillatory ventilation for the prevention of chronic lung disease of prematurity.

Johnson AH, Peacock JL, Greenough A, Marlow N, Limb ES, Marston L, Calvert SA; United Kingdom Oscillation Study Group.

N Engl J Med. 2002 Aug 29;347(9):633-42.

11.

Inhaled nitric oxide in infants >1500 g and <34 weeks gestation with severe respiratory failure.

Van Meurs KP, Hintz SR, Ehrenkranz RA, Lemons JA, Ball MB, Poole WK, Perritt R, Das A, Higgins RD, Stevenson DK.

J Perinatol. 2007 Jun;27(6):347-52. Epub 2007 Apr 19.

PMID:
17443204
12.

Inhaled nitric oxide in very preterm infants with severe respiratory distress syndrome.

Dani C, Bertini G, Pezzati M, Filippi L, Cecchi A, Rubaltelli FF.

Acta Paediatr. 2006 Sep;95(9):1116-23.

PMID:
16938760
13.

Neurodevelopmental outcomes of premature infants treated with inhaled nitric oxide.

Mestan KK, Marks JD, Hecox K, Huo D, Schreiber MD.

N Engl J Med. 2005 Jul 7;353(1):23-32.

14.

Noninvasive inhaled nitric oxide does not prevent bronchopulmonary dysplasia in premature newborns.

Kinsella JP, Cutter GR, Steinhorn RH, Nelin LD, Walsh WF, Finer NN, Abman SH.

J Pediatr. 2014 Dec;165(6):1104-1108.e1. doi: 10.1016/j.jpeds.2014.06.018. Epub 2014 Jul 22.

16.

Inhaled nitric oxide therapy in premature infants with mild to moderate respiratory distress syndrome.

Srisuparp P, Heitschmidt M, Schreiber MD.

J Med Assoc Thai. 2002 Aug;85 Suppl 2:S469-78.

PMID:
12403222
17.

A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.

Sinha SK, Lacaze-Masmonteil T, Valls i Soler A, Wiswell TE, Gadzinowski J, Hajdu J, Bernstein G, Sanchez-Luna M, Segal R, Schaber CJ, Massaro J, d'Agostino R; Surfaxin Therapy Against Respiratory Distress Syndrome Collaborative Group.

Pediatrics. 2005 Apr;115(4):1030-8.

PMID:
15805381
18.

High-frequency oscillatory ventilation versus conventional mechanical ventilation for very-low-birth-weight infants.

Courtney SE, Durand DJ, Asselin JM, Hudak ML, Aschner JL, Shoemaker CT; Neonatal Ventilation Study Group.

N Engl J Med. 2002 Aug 29;347(9):643-52.

19.

The safety and efficacy of nitric oxide therapy in premature infants.

Hascoet JM, Fresson J, Claris O, Hamon I, Lombet J, Liska A, Cantagrel S, Al Hosri J, Thiriez G, Valdes V, Vittu G, Egreteau L, Henrot A, Buchweiller MC, Onody P.

J Pediatr. 2005 Mar;146(3):318-23.

PMID:
15756211
20.

Effects of early inhaled nitric oxide therapy and vitamin A supplementation on the risk for bronchopulmonary dysplasia in premature newborns with respiratory failure.

Gadhia MM, Cutter GR, Abman SH, Kinsella JP.

J Pediatr. 2014 Apr;164(4):744-8. doi: 10.1016/j.jpeds.2013.11.040. Epub 2013 Dec 31.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk